This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiaowan Han - Innovator in Medicinal Chemistry
Introduction
Xiaowan Han is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating various diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Xiaowan Han holds a patent for an indolo[2',3′:3,4]pyrido[2,1-b]quinazoline compound. This compound is represented by a general formula and has multiple applications in the medical field. It can be used in the manufacture of a medicament for treating cardiovascular and cerebrovascular diseases. Additionally, it serves as a formulation for increasing the expression of AMPK, ABCA1, and SR-BI. The compound also activates nuclear receptors while inhibiting the activity of NLRP3, IL-1β, NF-κB, and MAPKs. Furthermore, it promotes cellular cholesterol efflux and can be utilized as a medicament for anti-inflammation.
Career Highlights
Xiaowan Han is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Xiaowan collaborates with esteemed colleagues, including Shuyi Si and Yanni Xu, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their projects.
Conclusion
Xiaowan Han is a prominent inventor whose work in medicinal chemistry is paving the way for new treatments and therapies. His patent for the indolo[2',3′:3,4]pyrido[2,1-b]quinazoline compound exemplifies his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile